The American College of Cardiology announced a collaboration with the Society for Vascular Surgery focused on a single vascular registry to improve outcomes and care for patients with vascular disease.
Among patients with venous outflow obstruction, a self-expanding venous stent system was safe and effective, researchers reported at the virtual Charing Cross Symposium.
The guidelines, unveiled at the society’s Scientific Sessions and simultaneously published in Catheterization and Cardiovascular Interventions, reviewed the following device options for aortoiliac artery procedures: percutaneous transluminal angioplasty with uncoated balloons, PTA with specialty balloons, drug-coated balloon angioplasty, balloon-expandable bare-metal stents, self-expanding BMS, balloon-expandable covered stents, self-expanding covered stents, drug-eluting stents and atherectomy.
Developers are using artificial intelligence to help researchers comb through thousands of studies and find relevant COVID-19 information for the development of potential treatments and vaccines.
Pacemakers or implanted cardiac defibrillators that were retrieved postmortem, resterilized and reused in underserved countries conferred similar rates of infection and device-related deaths as new devices implanted in Canada.
Catheter-based renal denervation was superior to a sham procedure for reducing BP in the absence of antihypertensive medications in patients with uncontrolled hypertension, according to results of the SPYRAL HTN-OFF MED pivotal trial.
Total annual spending per person with employer-sponsored health insurance increased 18.4% to nearly $5,900 between 2014 and 2018, according to a Health Care Cost Institute report.
Among patients who underwent PCI or CABG between 2003 and 2016, risk-adjusted mortality decreased in the CABG population but not in the PCI population over time, researchers reported in JAMA Network Open.
February is American Heart Month, and Feb. 7 is National Wear Red Day, an American Heart Association initiative that aims to raise awareness of heart disease as the leading cause of death for 1 in 3 American women and to serve as a catalyst to improve the health of women across the globe.
Renal denervation with catheter ablation in patients with paroxysmal atrial fibrillation and hypertension significantly increased the likelihood of freedom from AF at 12 months compared with catheter ablation alone, according to results of the ERADICATE-AF trial published in JAMA.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!